Cancer Pharmacology
Ashkan Emadi(University of Maryland, Baltimore), Donna Przepiorka(The University of Texas MD Anderson Cancer Center), Saurabh Dahiya(Stanford University), Katherine A. Scilla(University of Maryland, Baltimore), Crystal Lu(National Institutes of Health Clinical Center), Joshua F. Zeidner(University of North Carolina at Chapel Hill), Judith E. Karp(Emory University), Vincent C.O. Njar(University of Maryland, Baltimore), Amy M. Fulton(Duke University), Elizabeth M. Jaffee(Bloomberg (United States)), Richard F. Little(Dana-Farber Cancer Institute), Aleksandra Popović, Mehmet H. Kocoglu(University of Maryland, Baltimore), Scott H. Kaufmann(Mayo Clinic), Matthew D. Thompson(University of Arkansas for Medical Sciences), Mira A. Kohorst(Mayo Clinic), Lukasz P. Gondek(Johns Hopkins University), Gabriel Ghiaur(Johns Hopkins University), Alison Duffy, Ólanrewaju O. Okusanya, Justin Lawson, Christian Rolfo(Icahn School of Medicine at Mount Sinai), Mark Yarchoan(Sidney Kimmel Comprehensive Cancer Center), Katherine Tkaczuk(University of Mary), S. Percy Ivy(National Cancer Institute), Michael G. McCusker(University of Maryland, Baltimore), Arif Hussain(Baltimore VA Medical Center), Edward A. Sausville(University of Maryland, Baltimore), Sonia Esparza, Jean A. Yared(University of Maryland, Baltimore), Ciera Patzke, Ali Bukhari
Cited by 1
Related Papers
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
|The Lancet Oncology|2012|5.5k
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
|Science|2008|4k
Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer
|New England Journal of Medicine|2009|2.4k
Increase in<i>Candida krusei</i>Infection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with Fluconazole
|New England Journal of Medicine|1991|947